RosDok
metadata only
Establishment of preclinical tumor models for colorectal cancer precision medicine
Colorectal cancer (CRC) is the third most prevalent and second deadliest cancer worldwide. This prospective cohort study established patient-derived CRC organoids (75% success rate) and tumor-infiltrating lymphocytes (TILs, 87.5% success rate) as preclinical models for therapy prediction. Targeted N
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Three-dimensional heterotypic colorectal cancer spheroid models for evaluation of drug response#1175218
- Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma#411875
- 3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases#882681
- Response Prediction of Hyperthermic Intraperitoneal Chemotherapy in Gastro- Intestinal Cancer#847478
- A Multicellular 3D GelMA-Based Colorectal Cancer Model for Chemotherapeutic Responses.#151491
Record · ID 1092467
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive